Related Experiment Video

Updated: May 21, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis

Pascal Meier1, Andreas Indermuehle, Bertram Pitt

  • 1The Heart Hospital London, University College London Hospital Trust, London, UK. pascalmeier74@gmail.com

BMC Medicine
|June 23, 2012
PubMed

Insights

Good coronary collateral circulation increases restenosis risk after percutaneous coronary intervention (PCI). Assessing collateral status pre-PCI aids risk stratification and treatment choices for better patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary collateral circulation (CCC) is a natural bypass network crucial for myocardial survival.
  • While beneficial for survival, CCC may elevate restenosis risk post-percutaneous coronary intervention (PCI).
  • Existing data from smaller studies suggest a link between robust collateralization and increased restenosis rates.

Purpose of the Study:

  • To systematically review and meta-analyze observational studies.
  • To investigate the impact of coronary collateral circulation on restenosis risk after PCI.
  • To provide evidence-based insights for clinical decision-making.

Main Methods:

  • Searched MEDLINE, EMBASE, and ISI Web of Science databases (2001-2011).
  • Utilized random effects models to calculate summary risk ratios (RR) for restenosis.
  • Defined the primary endpoint as angiographic restenosis exceeding 50%.

Main Results:

  • Analyzed 7 studies with 1,425 participants.
  • Good collateralization was significantly associated with increased restenosis risk (RR 1.40, P=0.009).
  • This association held true for both intracoronary pressure measurements (RR 1.37) and visual assessment (RR 1.41), and was stronger in stable CAD patients (RR 1.64).

Conclusions:

  • Good coronary collateralization elevates the risk of restenosis following PCI.
  • Pre-PCI assessment of CCC can aid in risk stratification.
  • CCC evaluation may guide the selection of antiproliferative measures, such as drug-eluting stents over bare-metal stents.
Abstract

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...